Delhi High Court Dismisses PIL On Clinical Trials Of Rotavirus Vaccine

by Shirley Johanna on October 15, 2015 at 6:38 PM
Delhi High Court Dismisses PIL On Clinical Trials Of Rotavirus Vaccine

A plea seeking a direction to restrain the Centre from conducting any further clinical trials of rotavirus vaccine in India has been dismissed by the Delhi High Court. The court said that the petition "does not deserve to be taken cognizance as a Public Interest Litigation."

Rotavirus vaccine protects children from viruses, which are the leading cause of severe diarrhea among infants and young children.


A bench of Chief Justice G Rohini and Justice Jayant Nath said no case of violation of any statutory provision is made out in the present petition and no case is also made out to show that disclosure of the segregated data of clinical trial is essential in public interest.

"We, therefore, find substance in the submission of the Additional Solicitor General (ASG) that the petition is misconceived and motivated with private interest. For the aforesaid reasons, the petition does not deserve to be taken cognizance as a Public Interest Litigation," the bench said.

The court's order came on a plea filed by Dr Jacob Puliyel, a member of National Technical Advisory Group on Immunization (NTAGI) seeking to restrain the government from moving on to phase IV trials in which over one lakh children would be administered the vaccine.

Puliyel in his plea has also sought directions to the government to provide complete data of the multi-center clinical trials of the vaccine.

The bench said NTAGI, which is the highest technical advisory body in the country on immunization on on being satisfied about its efficacy and safety, has recommended to introduce the vaccine in question for National Immunization Program.

"In the circumstances, we do not find any substance in the contention of the petitioner that in the absence of the information about the number of cases of intussusceptions in clinical trial at one of the centers, the Government cannot be allowed to proceed to take up Phase-IV study of the vaccine," the bench said.

Source: PTI
Font : A-A+



Recommended Readings

Latest Indian Health News

BMC's Rs 1,500-Crore 'CM Health At Doorstep' Scheme for Mumbai
The Rs 1,500 crore 'Chief Minister Health at Doorstep' program aims to cut expenses and conduct blood tests for those aged 60+.
WHO Team Probes Mysterious Disease in Bihar
In Bihar, a mysterious ailment named "Langda fever" by locals has emerged, causing patients to recover from fever but struggle to walk due to joint pain.
Tobacco's Devastating Impact on India Revealed
Upon analyzing the years of life lost due to cancer, the team discovered that the four avoidable risk factors led to an annual loss of over 30 million years of life.
Poor Air Quality in Delhi Worsens Asthma Risk
Over the past three to four weeks in Delhi, there has been an increase of 20-30% in patients with recurring cough and upper respiratory tract infections.
First Lactarium Launches in Uttar Pradesh's Taj City
Premature infants with gastrointestinal complications and metabolic disorders stand to benefit the most from this Lactarium initiative.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Delhi High Court Dismisses PIL On Clinical Trials Of Rotavirus Vaccine Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests